Related Experiment Video
Updated: Jun 9, 2026

02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Protocol for a population-based ankylosing spondylitis (PAS) cohort in Wales
Mark D Atkinson1, Sinead Brophy, Stefan Siebert
1School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, UK. m.atkinson@swansea.ac.uk
BMC Musculoskeletal Disorders
|September 3, 2010
Summary
A new Welsh cohort links patient data, clinical records, and routine health information to study ankylosing spondylitis (AS) history and economic costs. This integrated approach offers valuable insights for patients and healthcare providers.
Area of Science:
- Rheumatology
- Health Informatics
- Epidemiology
Background:
- Ankylosing spondylitis (AS) is a chronic inflammatory disease requiring comprehensive data for effective management.
- Existing data sources are often fragmented, hindering a holistic understanding of AS.
- Population-based cohorts are crucial for studying chronic conditions like AS.
Purpose of the Study:
- To establish a comprehensive, population-based cohort of individuals with ankylosing spondylitis (AS) in Wales.
- To integrate diverse data sources, including clinical, patient-reported, and routine health data.
- To investigate the disease history and health economic impact of AS.
Main Methods:
- Utilizing a data linkage system to combine secondary care clinical datasets (rheumatologist notes).
- Incorporating patient-derived questionnaire data on disease activity, function, and quality of life.
- Linking with routinely collected data from GP records, hospital admissions, and laboratory results.
Main Results:
- The developed data model successfully integrates patient-supplied, primary, and secondary care data.
- This unified model enables the study of AS disease history and economic costs.
- The methodology facilitates research into severe disease factors and medication adverse events.
Conclusions:
- The integrated cohort provides a robust platform for understanding ankylosing spondylitis.
- This approach offers significant benefits for patients, clinicians, and healthcare managers.
- This pilot project demonstrates the potential of linked data cohorts for other chronic diseases.